Meridiem Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$83.1M |
| 2 |
Mastercard
MA
|
+$36.2M |
| 3 |
Analog Devices
ADI
|
+$32.7M |
| 4 |
Abbott
ABT
|
+$32.6M |
| 5 |
Boston Scientific
BSX
|
+$30M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$38.5M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$38.2M |
| 3 |
Netflix
NFLX
|
+$33.6M |
| 4 |
Edwards Lifesciences
EW
|
+$27M |
| 5 |
Zimmer Biomet
ZBH
|
+$26.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.87% |
| 2 | Healthcare | 19.73% |
| 3 | Communication Services | 15.89% |
| 4 | Consumer Discretionary | 12.16% |
| 5 | Financials | 5.26% |
Similar funds
Meridiem Capital Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Meridiem Capital Partners held 100 positions worth $1.42B, up 48% from $959M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Meridiem Capital Partners deployed $288M of net new capital in Q2 2025, opening 44 new positions and adding to 20 existing holdings. Its largest new stake was T-Mobile US: 340,500 shares worth $81.1M.
By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 33% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was Netflix, an estimated $33.6M trimmed.
- Meridiem Capital Partners's largest Q2 2025 buy was T-Mobile US: 340,500 shares worth $81.1M.
- Meridiem Capital Partners added most to Boston Scientific in Q2 2025, an estimated $30M increase.
- Meridiem Capital Partners's biggest Q2 2025 reduction was Netflix, cutting an estimated $33.6M.
- Meridiem Capital Partners fully exited Danaher in Q2 2025, selling an estimated $38.5M.
- Meridiem Capital Partners's ten largest holdings make up 37% of its $1.42B portfolio in Q2 2025.
- Meridiem Capital Partners opened 44 new positions and closed 28 in Q2 2025.
- Meridiem Capital Partners's portfolio value rose 48% quarter-over-quarter to $1.42B.
Based on Meridiem Capital Partners's 13F filing for Q2 2025, filed 14 Aug 2025.